Join us on Friday March 3rd, 2023 at 1pm. No cost and open to all.
FREE ON-LINE WEBINAR: Utility of Psychedelics for Psychological and Existential Distress in Palliative and End-of-Life Care presented by Anthony P. Bossis, PhD. New York University School of Medicine.
This presentation will review the history and recent findings from psychedelic research for the alleviation of psychosocial and existential suffering associated with a life-threatening illness or near the end of life. The NYU School of Medicine clinical trial published in 2016 (concurrently with a similar trial at Johns Hopkins) demonstrated the efficacy of a single psilocybin-generated experience in helping individuals with cancer cultivate meaning, enhance existential and psycho-spiritual well-being, and foster a greater acceptance of the dying process with less anxiety. The scientific findings of a rapid decrease in depression, anxiety, hopelessness, and demoralization, along with improvements in spiritual well-being and quality of life will be presented. Psilocybin is the psychoactive compound found in specific species of mushrooms. Implications for the future of palliative and hospice care will be addressed.
About our speaker: Anthony P. Bossis, Ph.D., is a clinical assistant professor of psychiatry at NYU School of Medicine, an adjunct professor of classics and religious studies at the University of Ottawa, and an Investigator at The Lundquist Institute for Biomedical Innovation. Since 2006, he has been conducting FDA-approved clinical research with the psychedelic compound psilocybin. Dr. Bossis was director of palliative care research and co-principal investigator on the 2016 clinical trial demonstrating a significant reduction in emotional distress from a single psilocybin session in persons with cancer. He is the study director and lead therapist on a clinical trial investigating a psilocybin-generated mystical experience upon religious leaders. Dr. Bossis is a training supervisor of psychotherapy at NYU-Bellevue Hospital and co-founder and former co-director of the Bellevue Hospital Palliative Care Service. He is on the editorial board of the Journal of Humanistic Psychology and a guest editor (with Charles Grob, M.D.) for the journal’s Special Series on Psychedelics. His primary research interests in the study of psychedelics are for the treatment of end-of-life existential distress and to advance our understanding of consciousness, meaning, and spirituality. He has a long-standing interest in studying comparative mystical experience and the interface of psychology and spirituality. He maintains a private psychotherapy and consulting practice in NYC.